FY2022 Earnings Estimate for Aspen Pharmacare Issued By Jefferies Group (APNHY)

Aspen Pharmacare (OTCMKTS:APNHY) – Equities researchers at Jefferies Group lifted their FY2022 earnings per share (EPS) estimates for shares of Aspen Pharmacare in a report issued on Wednesday. Jefferies Group analyst J. Vane-Tempest now expects that the company will earn $2.14 per share for the year, up from their prior forecast of $2.00.

Separately, Zacks Investment Research raised Aspen Pharmacare from a “hold” rating to a “buy” rating and set a $25.00 target price for the company in a report on Thursday, October 26th.

Shares of Aspen Pharmacare (OTCMKTS:APNHY) traded down $0.07 during midday trading on Thursday, hitting $21.20. The stock had a trading volume of 20,231 shares, compared to its average volume of 12,269. Aspen Pharmacare has a twelve month low of $19.45 and a twelve month high of $24.30. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.09 and a quick ratio of 0.70.

COPYRIGHT VIOLATION WARNING: “FY2022 Earnings Estimate for Aspen Pharmacare Issued By Jefferies Group (APNHY)” was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at https://www.tickerreport.com/banking-finance/3147713/fy2022-earnings-estimate-for-aspen-pharmacare-issued-by-jefferies-group-apnhy.html.

Aspen Pharmacare Company Profile

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies branded and generic pharmaceutical products, infant nutritionals, and consumer healthcare products. The company offers various branded products for a range of therapeutic categories, including anaesthetics, analgesics, anti-retrovirals, blood and haemopoetic, cardio vascular system, central nervous system, endocrine system, gastro-intestinal tract, infant milk formulations, musculo-skeletal agents, NSAIDs, oncology, oral hygiene, respiratory system, and urinary tract system, as well as ear, nose, and throat.

Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.